Medicover AB (publ) (OTCMKTS:MCVEF – Get Free Report) and Encompass Health (NYSE:EHC – Get Free Report) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, dividends, earnings, risk, analyst recommendations, valuation and profitability.
Earnings and Valuation
This table compares Medicover AB (publ) and Encompass Health”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Medicover AB (publ) | N/A | N/A | N/A | N/A | N/A |
| Encompass Health | $5.94 billion | 2.05 | $566.20 million | $6.14 | 20.13 |
Institutional and Insider Ownership
97.3% of Encompass Health shares are owned by institutional investors. 1.8% of Encompass Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
Analyst Recommendations
This is a summary of recent ratings and recommmendations for Medicover AB (publ) and Encompass Health, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Medicover AB (publ) | 0 | 0 | 0 | 0 | 0.00 |
| Encompass Health | 0 | 1 | 7 | 1 | 3.00 |
Encompass Health has a consensus target price of $148.71, suggesting a potential upside of 20.34%. Given Encompass Health’s stronger consensus rating and higher probable upside, analysts clearly believe Encompass Health is more favorable than Medicover AB (publ).
Profitability
This table compares Medicover AB (publ) and Encompass Health’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Medicover AB (publ) | N/A | N/A | N/A |
| Encompass Health | 10.01% | 18.08% | 8.22% |
Summary
Encompass Health beats Medicover AB (publ) on 10 of the 10 factors compared between the two stocks.
About Medicover AB (publ)
Medicover AB (publ) provides healthcare and diagnostic services in Poland, Sweden, and internationally. The company’s Healthcare services includes service outpatient and inpatient care; dental services; other services, including non-medical related services, such as sports memberships, benefit cards, and optics, as well as wellness services; hospital care; and preventive care. Its Diagnostic services comprise various tests, including allergy and autoimmune diagnostics, bacteriology, parasitology, biochemistry and immunochemistry, blood group diagnostics/transfusion medicine, tumour markers, clinical chemistry, cytology, haematology, histopathology, human genetics, hygiene, immunology and immunochemistry, infectious diseases, microbiology, molecular biology, and pharmacology/toxicology. It serves corporate, individuals, and public payers. Medicover AB (publ) was founded in 1995 and is headquartered in Stockholm, Sweden.
About Encompass Health
Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions. It offers services through the Medicare program to federal government, managed care plans and private insurers, state governments, and other patients. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. The company was incorporated in 1984 and is based in Birmingham, Alabama.
Receive News & Ratings for Medicover AB (publ) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicover AB (publ) and related companies with MarketBeat.com's FREE daily email newsletter.
